Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval

Detroit Decriminalizes Psychedelics

Detroit is the latest to join the growing list of U.S. cities that have decriminalized psychedelic substances.

The measure under which the Motor City will “decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of entheogenic plants by adults,” received approximately 62% votes in favor and 38% against, reported Marijuana Moment.

Under the new policy, “the personal possession and therapeutic use of entheogenic plants by adults” would be considered among Detroit’s “lowest law-enforcement priority.”

In October Seattle became the largest U.S. city to decriminalize psychedelic substances. Other cities that have decriminalized some or all entheogens include Oakland and Santa Cruz, California; Denver, Colorado and Ann Arbor, Michigan. 

made headlines several times this year concerning its psychedelics decriminalization bill, which has already passed several committees.

Filament Health To Launch First U.S. Trial Using Plant-derived Psychedelics

Psychedelic drug discovery company Filament Health Corp. (OTCQB: FLHLF)(NEO: FH) obtained approval to start the first ever clinical trial using naturally-sourced psychedelic substances in the U.S.  

The phase 1 trial has been designed to include 20 healthy subjects and will examine the effects of Filament’s three proprietary botanical drug candidates: PEX010 (oral psilocybin), PEX020 (oral psilocin) and PEX030 (sublingual psilocin).

“Our innovative technology has allowed us to create IP-protected botanical drug candidates of oral psilocin, sublingual psilocin, and oral psilocybin, and to enter them into an -approved natural psychedelic clinical trial. Our candidates enjoy significant IP protection, unlike most other psychedelics currently under clinical investigation,” CEO Benjamin Lightburn said.

Compass To Launch Phase 2 Trial On Psilocybin For PTSD

Shares from Compass Pathways (NASDAQ: CMPS) are …

Full story available on Benzinga.com

More Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval